Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 18 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis

  • Yuchen Fang1
  • Lianjun Xing1
  1. 1Department II of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Read full textPDFDOICite

Related

  1. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
    Shi-ping Sun, Yan Fang, Li Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Redox Dysregulation in the Abdominal Aortic Aneurysm Wall: Ferroptosis and Experimental Therapeutic Opportunities
    Yi Huang, Feng Zhu, Chuanqi Cai +1
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Successive and Isoform-Specific Remodeling of Hepatic Drug-Metabolizing Enzymes during Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis Progression
    Yusuke Ando, Takumi Arai, Yuki Tsukui +4
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textPharmacology & toxicologyJ-STAGE
  5. Macrophage interferon regulatory factor 7 aggravates the progression of metabolic dysfunction-associated steatohepatitis.
    Xuhao Ni, Qingfa Bu, Yuan Liang +5
    Molecular biomedicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{fang2026commentary,
  title = {{Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis}},
  author = {Yuchen Fang and Lianjun Xing},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.3389/fphar.2026.1965553},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1965553/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis
AU  - Yuchen Fang
AU  - Lianjun Xing
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1965553
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1965553/full
SN  - 1663-9812
ER  -